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A. Sampling from the Posterior
We use Gibbs sampling to sample from the joint posterior distribution of the parameters: β, α, γ, λ, b o , and V 0 . The joint posterior does not have a closed form; however, given that the conditional posteriors either have a closed form or are log-concave, implementation of the Gibbs sampler is straight-forward. Let D denote the data and rest denote the remaining parameters. Then at each iteration of the Gibbs sampler, we proceed as follows:
1. Let β il = (β il0 , . . . , β ilp ) , i = 1, . . . , N, l = 1, . . . , q. Then use ARS to sample
where n j is the number of events in the jth interval and H ij (β, γ, 1) is H ij (β, γ, λ) evaluated with λ j = 1.
Sample
[α|rest, D] ∼ N p (µ α , Σ α ) , where µ α = Σ α N i=1 x i q l=1 V −1 0l (β il − b 0l ) + C −1 1 C 0 and Σ α = q N i=1 x i V −1 0l x i + C −1 1 −1 .
B. Estimating the predicted survival curve
Given the G MCMC samples, b
(g) 0 , α (g) , λ (g) , γ (g) and V (g) 0 , g = 1, . . . , G, we can estimate the predicted survival curve at a set of time points, u = u 1 , . . . , J, as follows.
Repeat the following steps for g = 1, . . . , G.
).
Calculate S
(g) k (u j ) = exp{− u j 0 λ (g) (t)e γ (g) ψ β (t)+ζ * (2−k) dt}, k = 1, 2.
The predicted survival curve at time u j is then, S k (u j ) = median(S (g) k (u j ), g = 1, . . . , G), k = 1, 2, where k = 1 indicates the treatment group and k = 2 is the non-treatment group.
